Sutura endoscópica (TORe) para tratar la reganancia ponderal tras bypass gástrico quirúrgico

Coll, Eduardo Espinet; Durán, Javier Nebreda; Breviere, Gontrand López-Nava; Neto, Manoel Galvão; Galán, Patricia Díaz; Valero, JA Gómez; Lolo, C Vila; Bacchiddu, S; Bautista-Castaño, Inmaculada; Comamala, A Juan-Creix

doi:10.1055/s-0037-1607497

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is hypothesized that the weight loss post TORe was secondary to reduction in GJA size, improved eating habits, quicker gastric emptying times, and induction of satiety by stimulating gastric stretch receptors [11,24,27,28]. Weight recidivism was reported to be due to genetic factors, lack of dietary compliance, or due to suture breakage/migration leading to dilation of the GJA after TORe [26][27][28]36].…”

Section: Discussionmentioning

confidence: 99%

“…Four studies [12, 23-25] ▶ Table 1 Quality assessment of the study with Newcastle Ottawa Scale and Jadad scale. considered post procedure GJA size < 10 mm and four studies [26][27][28][29] considered post-procedure GJA size < 12 mm to be technically successful. Absolute weight loss was calculated using the formula TORe weight-follow up weight and TWL was defined as (TORe weight-follow up weight)/TORe weight x 100 %.…”

Section: Definition Of Outcomesmentioning

confidence: 99%

See 1 more Smart Citation

Efficacy of transoral outlet reduction in Roux-en-Y gastric bypass patients to promote weight loss: a systematic review and meta-analysis

et al. 2020

View full text Add to dashboard Cite

Background and study aims Transoral outlet reduction (TORe) is an endoscopic procedure used in patients with weight gain post Roux-en-Y gastric bypass (RYGB). We performed a systematic review and meta-analysis to evaluate the efficacy and safety of TORe with a full-thickness suturing device for treating patients with weight regain after RYGB. Patients and methods We conducted a comprehensive search of several databases and conference proceedings including PubMed, EMBASE, Google-Scholar, MEDLINE, SCOPUS, and Web of Science databases (earliest inception to March 2020). The primary outcomes assessed were technical success, absolute weight loss (AWL) and percent of total weight loss (% TWL) at 3, 6, and 12 months after the procedure. The secondary outcomes assessed were pooled rate of adverse events (AEs), adverse event subtypes and association of size of gastrojejunal anastomosis (GJA) and percent TWL. Results Thirteen studies on 850 patients were included. The pooled rate of technical success was 99.89 %. The absolute weight loss (kg) at 3, 6, and 12 months was 6.14, 10.15, and 7.14, respectively. The percent TWL at 3, 6, and 12 months was 6.69, 11.34, and 8.55, respectively. The pooled rate of AE was 11.4 % with abdominal pain being the most common adverse event. The correlation coefficient (r) was –0.11 between post TORe GJA size and weight loss at 12 months. Conclusion TORe is an endoscopic procedure that is safe and technically feasible for post RYGB with weight gain.

show abstract